tbuckley/cabot-search huggingface dataset:
Chromosomal Alterations in Gene Expression-Defined Pediatric Aggressive B-Cell Non-Hodgkin Lymphoma (B-NHL).
Authors: Karen E Deffenbacher, Javeed Iqbal, Zhongfeng Liu, Sherrie L. Perkins, Megan S Lim, Kai Fu, Yulei Shen, Louis M. Staudt, Lisa M. Rimsza, Elaine S Jaffe, Andreas Rosenwald, German Ott, Jan Delabie, Elias Campo, Randy D. Gascoyne, Dennis D. Weisenburger, Timothy C. Greiner, Thomas Gross, Wing C. Chan
Journal: Blood (2009)
Germline Mitochondrial DNA Mutations As a Novel First Event in Childhood Myelodysplastic Syndrome
Authors: Andrica de Vries, Christian M. Zwaan, H. Berna Beverloo, Anja Wagner, Arjan Lankester, Peter te Boekhorst, Rene de Coo, Kees Schoonderwoerd, Bert Smeets, Sophia Polychronopoulou, Rob Pieters, Marry M. van den Heuvel
Journal: Blood (2011)
BCR/ABL Tyrosine 177 Complexes with Grb2, Gab2 and Shp2, and Plays a Critical Role in Akt Activation and Altered p27 Signaling in BCR/ABL Transformed Human CD34+ Cells.
Authors: Su Chu, Liang Li, Harjeet Singh, Ravi Bhatia
Journal: Blood (2005)
Autologous Bone Marrow Stem Cells (ABMC) for Cardiormyoplasty in 15 Patients with Acute and Chronic Myocardial Disease (ACMD) in Colombia.
Authors: Francisco Cuéllar-Ambrosi, Juan Manuel Senior-Sánchez, Oscar Velásquez-Uribe, Claudia Navas-Rios, Juan Luis Londoño-Blair, Margarita Velásquez-Lopera
Journal: Blood (2005)
Troglitazone and Prochloroperazine Repositioned As An Anti-Leukemia Stem Cell Drug Combination Using Chemical Genomics-Based Prediction
Authors: Duane C Hassane, Jeanne P. De Leon, Cheryl Corbett, Randall M Rossi, Wen Xie, Craig T. Jordan, Monica L. Guzman
Journal: Blood (2011)
CHIR-258 Efficacy in a Newly Developed Preclinical Bone Marrow Model of t(4;14) Multiple Myeloma.
Authors: Xiaohua Xin, Yan Tang, Yoko Oei, Helen Ye, Daniel Menezes, Katherine Rendahl, Paul Hollenbach, Nancy Pryer, Suzanne Trudel, Dirk Mendel, Bahija Jallal, Carla Heise
Journal: Blood (2005)
Comparative Effectiveness of Generic Imatinib and Brand-Name Imatinib for the Treatment of Chronic Myeloid Leukemia
Authors: Adi J Klil-Drori, Laurent Azoulay, Hui Yin, Michel-Olivier Gratton, Michaël Harnois, Ines Chamakhi, Robert Delage, Pierre Laneuville, Luigina Mollica, Harold J. Olney, Lambert Busque, Sarit E. Assouline
Journal: Blood (2015)
Decitabine Induces High Response Rates in Patients with Chronic Myelomonocytic Leukemia (CMML).
Authors: Elias Jabbour, Susan O’Brien, Farhad Ravandi-Kashani, Jorge Cortes, Gautam Borthakur, Srdan Verstovsek, Guillermo Garcia-Manero, Francis Giles, Lourdes Zanoria, Jan Davisson, Jean-Pierre Issa, Hagop M. Kantarjian
Journal: Blood (2006)
RPS29 is Mutated in a Multi-Case Diamond Blackfan Anemia Family
Authors: Lisa Mirabello, Bari J. Ballew, Neelam Giri, Kevin B. Jacobs, Meredith Yeager, Joseph F. Boland, Belynda D. Hicks, Laurie Burdett, Amy A. Hutchinson, Blanche P. Alter, Sharon A. Savage
Journal: Blood (2012)
Down-Regulation of Microrna 223 and 148a Mediates Resistance of Human Acute Myeloid Leukemia Cells to Pan-Histone Deacetylase (HDAC) Inhibitors.
Authors: Jianguang Chen, Veena Kandaswamy, Warren Fiskus, Yongchao Wang, Rekha Rao, Ramesh Balusu, Kathleen M. Buckley, Peter Atajada, Kapil N. Bhalla
Journal: Blood (2009)
Human SH2B1 mutations are associated with maladaptive behaviors and obesity
Authors: Michael E. Doche, Elena G. Bochukova, Hsiao-Wen Su, Laura R. Pearce, Julia M. Keogh, Elana Henning, Joel M. Cline, Sadia Saeed, Anne Dale, Tim Cheetham, Inês Barroso, Lawrence S. Argetsinger, Stephen O’Rahilly, Liangyou Rui, Christin Carter-Su, I. Sadaf Farooqi
Journal: Journal of Clinical Investigation (2013)
Overall Survival and Subgroup Analysis from a Randomized Phase III Study of Intravenous Rigosertib Versus Best Supportive Care (BSC) in Patients (pts) with Higher-Risk Myelodysplastic Syndrome (HR-MDS) after Failure of Hypomethylating Agents (HMAs)
Authors: Guillermo Garcia-Manero, Pierre Fenaux, Aref Al-Kali, Maria R. Baer, Mikkael A. Sekeres, Gail J. Roboz, Gianluca Gaidano, Bart L. Scott, Peter L. Greenberg, Uwe Platzbecker, David P. Steensma, Suman Kambhampati, Karl-Anton Kreuzer, Lucy A Godley, Robert Collins, Ehab Atallah, Francois Wilhelm, Isabelle E. Wilhelm, Nozar Azarnia, Manoj Maniar, Lewis R. Silverman
Journal: Blood (2014)
Differential impacts of Oncotype DX and Mammostrat prognostic indices upon the management of ER+ N0 breast cancer.
Authors: Jeffrey Gary Schneider, Lorna Ogden, Nosha Farhadfar, George Turi, Danny Khalil
Journal: Journal of Clinical Oncology (2013)

599 Background: Oncotype DX (Genomic Health, Redwood City CA) and Mammostrat (Clarient, Aliso Viejo CA) are two distinct prognostic measures currently marketed to facilitate adjuvant chemotherapy decision making for ER+ breast cancer patients and their physicians. Both assays define three prognostic strata—favorable, intermediate, and unfavorable. Both assays were also validated in the same retrospective cohorts, but there is significant discordance between these assays, suggesting that assay selection may affect clinical decisions. Methods: We have previously reported that Oncotype DX significantly reduces adjuvant chemotherapy use in 89 consecutive ER+, N0 patients for whom this assay was ordered at our institution. Mammostrat assays were performed on 46 of these cases for which tumor blocks were available. Decision analysis was applied to determine changes in management that would have been most likely if Mammostrat had been substituted for Oncotype DX. Results: Oncotype DX and Mammostrat were concordant for prognostic strata in just 11 (24%) cases. Oncotype DX predicted a more favorable prognosis than Mammostrat in 27 (59%) cases, while Mammostrat predicted a more favorable prognosis in the remaining 8 (17%) cases. As shown in the Table, Oncotype DX reduced chemotherapy utilization whereas Mammostrat would have increased it. Conclusions: Despite being validated in identical patient cohorts, Oncotype DX and Mammostrat are frequently discordant and may often affect adjuvant treatment decisions in opposite directions. [Table: see text]
Differential Expression of Type I MAGE in New and Relapsed Multiple Myeloma: Evidence for Association with Proliferation and Progression of Disease.
Authors: Hearn J. Cho, Scott Ely, Wayne R. Austin, Ruben Niesvizky, Roger Pearse, Morton Coleman, Nina Bhardwaj, Maurizio DiLiberto, Selina Chen-Kiang, Lloyd J. Old, Achim A. Jungbluth
Journal: Blood (2006)
Interim Results of a Phase 1 Trial of An Oral Histone Deacetylase Inhibitor Belinostat In Patients with Lymphoid Malignancies.
Authors: Jasmine M. Zain, Francine M Foss, Johann S. de Bono, Ameet Narwal, Ellen Neylon, George Blumenschein, U. Lassen, Poul Knoblauch, Catherine S. Diefenbach, Owen A. O'Connor
Journal: Blood (2010)
CXCR4 Promotes the Tumorogenicity of Multiple Myeloma, Including Increased Motility, Clonogenicity, up-Regulation of VLA-4, Protection From Chemotherapy and Aggressive Tumor Development In Vivo
Authors: Katia Beider, Amnon Peled, Lola Weiss, Merav Leiba, Avichai Shimoni, Arnon Nagler
Journal: Blood (2011)
Lenalidomide Induces Complete and Partial Responses in Patients with Relapsed and Treatment-Refractory Chronic Lymphocytic Leukemia (CLL).
Authors: Alessandra Ferrajoli, Susan M. O’Brien, Stefan H. Faderl, William G. Wierda, Dietrich Davis, Bang-Ning Lee, James M. Reuben, Ellen J. Schlette, Hagop M. Kantarjian, Michael J. Keating
Journal: Blood (2006)
Sporadic rectal cancers in young adults: Experience from a tertiary cancer center in India.
Authors: Monica Malik, Kesava Ramgopal Adavikolanu, Swapna Jilla, Vindhya Vasini Andra, Yugandhar Lella, K. V. Jagannath Rao Naidu, Suresh Pamidighantam, Venkata Ratnam Sunkavalli
Journal: Journal of Clinical Oncology (2013)

e14694 Background: Recent years have witnessed a trend towards an increase in incidence of rectal cancers in young adults both in western and asian populations. It has been noted that these cancers are more aggressive and associated with poorer outcomes. Methods: We conducted a retrospective analysis of young adults (age ≤ 40 years) with rectal cancers treated at our institute from 2007 to 2012. Information regarding stage, histology, treatment and outcomes were collected from patient records. Patients/family members were contacted for information regarding demographic, socioeconomic, dietary habits and occupational parameters. Disease free and overall survival was analyzed by Kaplan Meier estimates using the SPSS version 20. Results: A of total of 153 cases of rectal cancer were treated between 2007 to 2012 of which 48 patients (31%) were ≤ 40 years of age. Median age at presentation for the younger patients (≤40 years) was 30 years. There were 29 males and 19 females. None of these patients had a positive family history and no synchronous cancers were detected. Six patients were agricultural laborers and four worked in coal or cement factories. 23% of patients hailed from the coastal agricultural belt. At presentation, 41 patients had locally advanced disease and 7 had distant metastases. 25 patients received neoadjuvant chemoradiation, 17 underwent surgery and adjuvant chemoradiation and 6 were treated with palliative intent. Four patients progressed during treatment and eight had recurrent disease during follow up. Median overall survival (OS) was 21 months. 5-year OS was 37.5%. On multivariate analysis, poorly differentiated/mucinous tumors were associated with worse survival (p=0.01). Conclusions: 2-10% of colorectal cancers are reported to occur in young adults with many showing a familial association. In our series we had a higher proportion of young adults with sporadic cancers. Various occupational and environmental factors may be associated with these cancers. They are often detected in late stages and are associated with an aggressive course and unfavorable outcomes; hence early detection is of vital importance. Towards this end, identification of risk factors and screening programs need to be carried out.
Impact of Extramedullary Disease in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation: A Study By the EBMT Chronic Malignancies Working Party
Authors: Nico Gagelmann, Simona Iacobelli, Linda Koster, Hareth Nahi, Anne-Marie Stoppa, Tamás Masszi, Denis Caillot, Stig Lenhoff, Miklos Udvardy, Charles Crawley, William Arcese, Clara Mariette, Ann Hunter, Xavier Leleu, Martin Schipperus, Michel Delforge, Pietro Pioltelli, John A Snowden, Maija Itälä-Remes, Maurizio Musso, Laurent Garderet, Nicolaus Kröger
Journal: Blood (2016)
Clonal Hematopoiesis in AML Patients in Hematological CR Is Present in Many Patients with Intermediate Risk AML and Is Associated with a High Prevalence of DNMT3A gene Mutations
Authors: Anne Otto, Meredith Lilly, Sylvia Herold, Caroline Schuster, Christoph Röllig, Uwe Platzbecker, Johannes Schetelig, Martin Bornhäuser, Gerhard Ehninger, Christian Thiede
Journal: Blood (2014)
Genome Wide DNA Methylation Analysis Reveals Significant Differences Between Blasts of Patients with Acute Promyelocytic Leukemia and CD34+-Hematopoietic Stem Cells of Healthy Individuals
Authors: Mark Reinwald, Anjulie Haag, Eva Lengfelder, Verena Nowak, Maximilian Mossner, Marion Klaumuenzer, Florian Nolte, Thomas Büchner, Karsten Spiekermann, Wolf-Karsten Hofmann, Daniel Nowak
Journal: Blood (2011)
A Phase II Trial of Ofatumumab in Subjects with Waldenstrom's Macroglobulinemia,
Authors: Richard R. Furman, Herbert Eradat, Christine Gabriella DiRienzo, Suzanne R Hayman, Craig C. Hofmeister, Nathalie A. Avignon, John P. Leonard, Morton Coleman, Ranjana Advani, Julie C. Switzky, Qiming Liao, Damini N. Shah, Steen Lisby, Thomas S Lin
Journal: Blood (2011)
Inhibition of Thrombin-Induced Platelet Aggregation Using Human Single Chain Fv Antibodies Specific for TREM-Like Transcript-1.
Authors: A. Valance Washington, Barbara Giomarelli, Maia M. Chisholm, Laura Quigley, James B. McMahon, Toshiyuki Mori, Daniel W. McVicar
Journal: Blood (2006)
Phosphatidylserine-Mediated Platelet Clearance By Endothelium Decreases Platelet Aggregates and Procoagulant Activity in Sepsis
Authors: Ruishuang Ma, Xiaoming Wu, Lixiu Wang, Lu Zhao, Yan Zhang, Zhipeng Yao, Tao Li, Muhua Cao, Junjie Kou, Yayan Bi, Jin Zhou, Jialan Shi
Journal: Blood (2016)
Macroporous heparin-based microcarriers allow long-term 3D culture and differentiation of neural precursor cells
Authors: Ben Newland, Fanny Ehret, Franziska Hoppe, Dimitri Eigel, Dagmar Pette, Heike Newland, Petra B. Welzel, Gerd Kempermann, Carsten Werner
Journal: Biomaterials (2019)
Comparable Immune Reconstitution Between Ex Vivo Amplification and Un-Manipulated Umbilical Cord Blood Transplantation
Authors: Edouard Forcade, Céline Cognet, Xavier Sicard, Sophie Daburon, Pascale Duchez, Zoran Ivanovic, Vincent Pitard, Julie Déchanet-Merville, Emmanuel Clave, Antoine Toubert, Stephane Vigouroux, Reza Tabrizi, Mathieu Sauvezie, Arnaud Pigneux, Jean-Francois Moreau, Noel Milpied, Jean-Luc Taupin
Journal: Blood (2015)
Activation of Rac1 through FARP1 Induces Dexamethasone Resistance in Multiple Myeloma Cells
Authors: Atsuko Yamazaki, Masahiro Takeuchi, Tatsuzo Mishina, Miki Yamazaki, Chika Kawajiri, Ryoh Simizu, Emi Togasaki, Yasumasa Sugita, Tomoya Muto, Shio Sakai, Yusuke Takeda, Naoya Mimura, Chikako Ohwada, Emiko Sakaida, Tohru Iseki, Chiaki Nakaseko
Journal: Blood (2014)
Evidence That HLA-B*40:02 and HLA-Α*31:01 Are Strongly Involved in the Presentation of Autoantigens to CTLs Responsible for the Development of Acquired Aplastic Anemia
Authors: Yoshitaka Zaimoku, Hiroyuki Maruyama, Kana Maruyama, Takamasa Katagiri, An T. T. Dao, Hiroyuki Takamatsu, Hirohito Yamazaki, Koichi Kashiwase, Shinji Nakao
Journal: Blood (2014)
Influence of Hydroxyurea on Neutrophil Microparticles: A SCA Model
Authors: Thassila Nogueira Pitanga, Rayra Pereira Santiago, Sanzio Silva Santana, Caroline Conceição Guarda, Júnia Raquel Dutra Ferreira, Vitor Valério Maffili, Dalila Luciola Zanette, Valma Maria Lopes, Ricardo Riccio Oliveira, Washington Luis Conrado Santos, Marilda Souza Goncalves
Journal: Blood (2016)
Hypermethylation of GADD45A Defines a Methylation Profile Distinct to Mutant IDH1/2, and Correlates with More Aggressive AML
Authors: Saumya E Samaraweera, Francine E. Garrett-Bakelman, Yaseswini Neelamraju, Michelle Perugini, Debora A. Casolari, Diana Iarossi, Sarah C Bray, Caroline Sheridan, Tak C Lee, Ing Soo Tiong, Silke Danner, Nik Cummings, Monica L. Guzman, Gail J. Roboz, Luen Bik To, Andrew Wei, Christopher E. Mason, Christopher Y. Park, Ross L. Levine, Martin Carroll, Michael W. Becker, Ian D Lewis, Ari Melnick, Richard D'Andrea
Journal: Blood (2016)
IGF1-Mediated Osteoblastic Niche Expansion After Marrow Ablation Enhances Long-Term Hematopoietic Stem Cell Engraftment and Hematopoietic Reconstitution After Bone Marrow Transplantation
Authors: Anna Caselli, Timothy S. Olson, Satoru Otsuru, Ted Hofmann, Paolo Paolucci, Massimo Dominici, Edwin M. Horwitz
Journal: Blood (2010)
Novel Homozygous Mutation (R329X) in the Hemojuvelin Gene Is Associated with Hypogonadotrophic Hypogonadism, Diabetes Mellitus and Heart Failure Duo to Juvenile Hemochromatosis.
Authors: Rong-Fu Zhou, Jian Ouyang, Xue-mei Guo, Bing Chen, Jing-yan Xu, Xiao-Yan Shao, Qi-Guo Zhang
Journal: Blood (2009)
Leukemic Stem Cells of Chronic Phase CML Patients Consistently Display Very High BCR-ABL Transcript Levels and Reduced Responsiveness to Imatinib Mesylate in Addition to Generating a Rare Subset That Produce Imatinib Mesylate-Resistant Differentiated Progeny.
Authors: Xiaoyan Jiang, Yun Zhao, Wing Yiu Chan, Emily Pang, Allen Eaves, Connie Eaves
Journal: Blood (2004)
Transcriptional profiling of circulating tumor cells in multiple myeloma: a new model to understand disease dissemination
Authors: Juan-Jose Garcés, Michal Simicek, Marco Vicari, Lucie Brozova, Leire Burgos, Renata Bezdekova, Diego Alignani, Maria-Jose Calasanz, Katerina Growkova, Ibai Goicoechea, Xabier Agirre, Ludek Pour, Felipe Prosper, Rafael Rios, Joaquin Martinez-Lopez, Pamela Millacoy, Luis Palomera, Rafael Del Orbe, Albert Perez-Montaña, Sonia Garate, Laura Blanco, Marta Lasa, Patricia Maiso, Juan Flores-Montero, Luzalba Sanoja-Flores, Zuzana Chyra, Alexander Vdovin, Tereza Sevcikova, Tomas Jelinek, Cirino Botta, Halima El Omri, Jonathan Keats, Alberto Orfao, Roman Hajek, Jesus F. San-Miguel, Bruno Paiva
Journal: Leukemia (2019)
Relapse Prediction By Flow Cytometric Minimal Residual Disease Assessment in Infants with Acute Lymphoblastic Leukemia
Authors: Alexander Popov, Tatiana Verzhbitskaya, Grigory Tsaur, Egor Shorikov, Liudmila Movchan, Mikhail Belevtsev, Anatoly Kustanovich, Olga Streneva, Olga Khlebnikova, Natalia Myakova, Dmitry Litvinov, Konstantin Kondratchik, Elmira Boychenko, Olga Aleinikova, Michael Maschan, Alexander Karachunskiy, Larisa Fechina
Journal: Blood (2016)
Valproic Acid (VPA), a Histone Deacetylase (HDAC) Inhibitor, Diminishes Lymphoproliferation in the Fas Deficient MRL/lpr−/− Murine Model of Autoimmune Lymphoproliferative Syndrome (ALPS).
Authors: Kennichi C. Dowdell, Lesley Pesnicak, Victoria Hoffman, Kenneth Steadman, Mark Ruddel, V. Koneti Rao, Stephen E. Straus
Journal: Blood (2006)
Genome-Wide Methylation Analysis of Patients with Diffuse Large B Cell Lymphoma Treated on the UK NCRI R-CHOP 14 Vs 21 Trial
Authors: Andrea Kühnl, Ridwan Shaikh, David Cunningham, Sharon L Barrans, Cathy H Burton, Andrew Jack, Mary Gleeson, Nicholas Counsell, Paul Smith, Oliver Schofield, David C. Linch, Michael Hubank
Journal: Blood (2016)
Phosphatidylinositol-3-Kinase p110d Uniquely Promotes Gain-Of-Function PTPN11-Induced GM-CSF Hypersensitivity In a Model Of Juvenile Myelomonocytic Leukemia
Authors: Charles B Goodwin, Raghuveer Mali, Gordon Chan, Benjamin Neel, Brian Lannutti, Reuben Kapur, Rebecca J. Chan
Journal: Blood (2013)
THU0412 Prevalence and Incidence of Osteoporotic Fractures in Patients on Long-Term Glucocorticoid Treatment for Rheumatic Diseases: The Glucocorticoid Induced Osteoporosis Tool, Giotto Study.
Authors: M. Rossini, N. Malavolta, G. La Montagna, S. Maddali Bongi, O. Di Munno, A. Del Puente, G. Minisola, M. Muratore, B. Frediani, M. Caminiti, L. Sinigaglia, F. P. Cantatore, G. D’Avola, S. Adami
Journal: Annals of the Rheumatic Diseases (2013)

<h3>Background</h3> Osteoporosis and fractures are common and invalidating consequences of chronic glucorticoid (GC) treatment. Reliable information regarding the epidemiology of GC induced osteoporosis (GIOP) are coming exclusively from the placebo group of randomized clinical trials while observational studies are generally lacking data on the real prevalence of vertebral fractures, GC dose and primary diagnosis. <h3>Objectives</h3> The objective of this study was to evaluate the incidence of osteoporotic fractures and to identify their major determinants (primary disease, GC dose, BMD values, specific treatment for GIOP, etc.) in a large cohort of consecutive patients aged &gt; 21 years, on chronic treatment with GC (≥5 mg prednisone –PN- equivalent), attending rheumatology centres located all over Italy. <h3>Methods</h3> Here the results of an interim analysis of the first 553 enrolled patients are presented. Systemic Lupus Erythematosus or other Connectivites (CON), Polymialgia Rheumatica (PMR), and Rheumatoid arthritis (RA) were the underlying diseases. <h3>Results</h3> In the table are shown the main clinical characteristics : <h3>Conclusions</h3> In real life the prevalence of clinical fractures in patients with rheumatic diseases is high even before GC treatment and the incidence of new clinical fractures while on chronic GC treatment (PN- equivalent ≥ 5 mg/day) is somewhat lower than hitherto assumed. These results emphasize the importance of the underlying disease in the risk of GIOP associated fractures. <h3>Disclosure of Interest</h3> None Declared
A Daily Struggle to Improve Kaplan-Meier Curves—Doctors on the Swing
Authors: Marco Badinella Martini
Journal: JAMA Oncology (2019)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients
Authors: Matilde Y Follo, Cristina Clissa, Sara Mongiorgi, Francesca Chiarini, Michele Baccarani, Giovanni Martinelli, Lucia Manzoli, Alberto M Martelli, Carlo Finelli, Lucio Cocco
Journal: Blood (2011)
Cord Blood (CB) Stability and Potency Evaluation: Consistent, Predictable Recovery of Hematopoietic Progenitor Cells (HPC) and High CD34+ Cell Viability in Stored Cord Blood Units (CBU) of the National Cord Blood Program (NCBP)
Authors: Andromachi Scaradavou, Ludy Dobrila, M Susana Albano, Michal Tarnawski, Tracy Zhu, Chiseko Watanabe, Dan Zamfir, Rodica Ciubotariu, Dorothy Sung, Pablo Rubinstein
Journal: Blood (2016)
Clinical introduction of Microsatellite instability (MSI) test for the Solid Tumors at a single institute
Authors: Izuma Nakayama, Eiji Shinozaki, Hiroshi Kawachi, Takeshi Nakajima, Takashi Sasaki, Ryo Kanata, Mayu Yunokawa, Maki Matoda, Jyunishi Tomomatsu, Satoshi Kitazono, Takeshi Yuasa, Kokoro Kobayashi, Chieko Toko, Kazumi Kaihara, Yasuhiro Nakano, Tomoyo Kakita, Shunnji Takahashii, Kensei Yamaguchi
Journal: Annals of Oncology (2019)
A Prospective Monocentric Study of Fractionated Gemtuzumab Ozogamicin (GO) Combined to Standard-Dose Cytarabine in Older Patients with Acute Myeloid Leukemia (AML) in First Relapse,
Authors: Sylvain Pilorge, Sophie Rigaudeau, Clémentine Sarkozy, Anne L Taksin, Hassan Farhat, Fatiha Merabet, Marcela Anitei, Stéphanie Ghez, Victoria Raggueneau, Isabel Garcia, Aline Renneville, Claude Preudhomme, Sylvie Castaigne, Philippe Rousselot
Journal: Blood (2011)
Mer Receptor Tyrosine Kinase Is A Potential Therapeutic Target in Acute Myeloid Leukemia
Authors: Alisa B. Lee-Sherick, Kelly Menachof, Kristen M. Eisenman, Amy McGranahan, Colleen McGary, Sally A. Hunsucker, Jennifer Schlegel, Paul M Armistead, Xiayuan Liang, Dmitri Kireev, William Janzen, Jing Liu, Michael Stashko, Jacqueline Norris-Drouin, H. Shelton Earp, Xiaodong Wang, Stephen Frye, Deborah DeRyckere, Douglas K. Graham
Journal: Blood (2012)
Treatment of Myelodysplastic Syndromes with del 5q before the Lenalidomide Era: The GFM Experience.
Authors: Charikleia Kelaidi, Sophie Park, Sabine Brechignac, Lionel Mannone, Norbert Vey, Herve Dombret, Lina Aljassem, Aspasia Stamatoullas, Lionel Adès, Stéphane Giraudier, Stéphane de Botton, Béatrice Mahé, Pascale Lepelley, Françoise Picard, Geneviève Leroux, Marie-Thérèse Daniel, Didier Bouscary, François Dreyfus, Pierre Fenaux
Journal: Blood (2006)
NPM-ALK Fusion Tyrosine Kinase of Anaplastic Large Cell Lymphoma Exerts Its Transforming Potential by Increasing Translation of JUNB through mTOR and S6K1.
Authors: Philipp B. Staber, Paul Vesely, Rene Ott, Naznin Haq, Werner Linkesch, Silvia Schauer, Andelko Hrzenjak, Lukas Kenner, Wilhelm Dirks, Marshall E. Kadin, David W. Sternberg, Gerald Hoefler
Journal: Blood (2006)